TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years December 4, 2023
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update November 10, 2023
TScan Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update November 10, 2023
Werewolf Therapeutics Presents Preliminary Monotherapy Data from Phase 1/1b Clinical Trial Establishing Proof of Mechanism for WTX-124 November 6, 2023
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 6, 2023
